- Musene, Kamy;
- Dzogang, Camille;
- Sinai, Cyrus;
- Spencer, DAndre;
- Ngoie-Mwamba, Guillaume;
- Tangney, Sylvia;
- Salet, Frank;
- Nyembwe, Michel;
- Kambamba Nzaji, Michel;
- Tambu, Merly;
- Mbala, Placide;
- Gerber, Sue;
- Kaba, Didine;
- Muyembe-Tamfum, Jean;
- Rimoin, Anne;
- Gadoth, Adva;
- Mukadi, Patrick;
- Fuller, Trevon;
- Hoff, Nicole;
- Halbrook, Megan
Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6-47.0%), 41.1% (38.0-44.2%), and 38.0% (34.9-41.0%) had protective neutralizing titers to polio types 1, 2, and 3, respectively. We found that 60.7% of parents reported knowing about polio, yet 25.6% reported knowing how it spreads. Our data supported the conclusion that polio outreach efforts were successfully connecting with communities-79.4% of participants had someone come to their home with information about polio, and 88.5% had heard of a polio vaccination campaign. Additionally, the odds of seroreactivity to only serotype 2 were far greater in health zones that had a history of supplementary immunization activities (SIAs) compared to health zones that did not. While SIAs may be reaching under-vaccinated communities as a whole, these results are a continuation of the downward trend of seroprevalence rates in this region.